Weifeng Ding
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Advanced biosensing and bioanalysis techniques
- Protein Interaction Studies and Fluorescence Analysis
- RNA Interference and Gene Delivery
- RNA modifications and cancer
Papers in
-
- RNA modifications and cancer 6
- Protein Interaction Studies and Fluorescence Analysis 5
- Epigenetics and DNA Methylation 5
- RNA Interference and Gene Delivery 4
- Advanced biosensing and bioanalysis techniques 4
-
- Cancer-related molecular mechanisms research 5
- Co-authors
- Yanyun Ma (10 shared papers)Feng Wang (3 shared papers)Jinbin Liu (4 shared papers)Huimin Wang (2 shared papers)Zhanguang Chen (4 shared papers)Fenglian Ren (4 shared papers)Jiucun Wang (7 shared papers)Xiaodong Zhou (7 shared papers)
- Journals
- Scientific Reports (2 papers)Clinical Biochemistry (2 papers)Pathology & Oncology Research (2 papers)DNA and Cell Biology (2 papers)Clinical Epigenetics (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Weifeng Ding
35 papers receiving 685 citations
Peers
Comparison fields: 5 of 95
- Cancer Research 122
- Molecular Biology 411
- Drug Discovery 1
- Pathology and Forensic Medicine 96
- Immunology 85
Countries citing papers authored by Weifeng Ding
This map shows the geographic impact of Weifeng Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Ding more than expected).
Fields of papers citing papers by Weifeng Ding
This network shows the impact of papers produced by Weifeng Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Ding. The network helps show where Weifeng Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Weifeng Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 94 | |
| 2 | 2017 | 68 | |
| 3 | 2005 | 66 | |
| 4 | 2017 | 51 | |
| 5 | 2018 | 35 | |
| 6 | 2017 | 34 | |
| 7 | 2016 | 31 | |
| 8 | 2017 | 31 | |
| 9 | 2009 | 25 | |
| 10 | 2021 | 22 | |
| 11 | 2011 | 21 | |
| 12 | 2005 | 18 | |
| 13 | 2009 | 17 | |
| 14 | 2013 | 17 | |
| 15 | 2013 | 17 | |
| 16 | 2018 | 17 | |
| 17 | 2019 | 14 | |
| 18 | 2020 | 14 | |
| 19 | 2013 | 12 | |
| 20 | 2011 | 11 |
About Weifeng Ding
Weifeng Ding is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 692 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Protein Interaction Studies and Fluorescence Analysis (5 papers), Epigenetics and DNA Methylation (5 papers), Cancer-related molecular mechanisms research (5 papers), RNA Interference and Gene Delivery (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Systemic Sclerosis and Related Diseases (4 papers). The work is most often cited by research in Cancer Research (122 citations), Molecular Biology (411 citations), Drug Discovery (1 citation), Pathology and Forensic Medicine (96 citations) and Immunology (85 citations). Weifeng Ding has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yanyun Ma, Feng Wang, Jinbin Liu, Huimin Wang, Zhanguang Chen, Fenglian Ren, Jiucun Wang, Xiaodong Zhou, Qingmei Liu and Haiquan Li. Their work appears in journals such as Scientific Reports, Clinical Biochemistry, Pathology & Oncology Research, DNA and Cell Biology and Clinical Epigenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.